These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38702191)

  • 1. Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic.
    Goldstein E; Moss E; Bennett-Slater S; Ferguson L; McInally C; McHugh M; Maxwell A; Winter A; Gunson RN
    Sex Transm Infect; 2024 May; 100(4):226-230. PubMed ID: 38702191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study.
    Mabonga E; Parkes-Ratanshi R; Riedel S; Nabweyambo S; Mbabazi O; Taylor C; Gaydos C; Manabe YC
    Int J STD AIDS; 2019 Mar; 30(3):256-263. PubMed ID: 30392463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx).
    Cotton S; McHugh MP; Etherson M; Shepherd J; Templeton KE
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115262. PubMed ID: 33388573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
    Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
    BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
    Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
    J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    Hadad R; Cole MJ; Ebeyan S; Jacobsson S; Tan LY; Golparian D; Erskine S; Day M; Whiley D; Unemo M;
    J Antimicrob Chemother; 2021 Jan; 76(1):84-90. PubMed ID: 32929456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay.
    Lee DYJ; Ashcroft MM; Chow EPF; Sait M; De Petra V; Tschaepe M; Lange S; Taiaroa G; Bradshaw CS; Whiley DM; Fairley CK; Howden BP; Chen MY; Pasricha S; Williamson DA
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33658263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
    BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
    BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
    Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M
    BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.
    Roy K; Wang SA; Meltzer MI
    Emerg Infect Dis; 2005 Aug; 11(8):1265-73. PubMed ID: 16102317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.